Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03996473
Title Study to Test the Safety and How Radium-223 Dichloride an Alpha Particle-emitting Radioactive Agent Works in Combination With Pembrolizumab an Immune Checkpoint Inhibitor in Patients With Stage IV Non-small Cell Lung Cancer With Bone Metastases
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Bayer
Age Groups: senior | adult
Covered Countries USA | ESP | BEL

Facility Status City State Zip Country Details
Ccare San Marcos Cancer Center & Urology San Marcos California 92069 United States Details
UZ Gent Gent 9000 Belgium Details
Nederlands Kanker Instituut Amsterdam 1066 CX Netherlands Details
Ciutat Sanitaria i Universitaria de la Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clínic i Provincial de Barcelona Barcelona 08036 Spain Details
Hospital Universitario 12 de Octubre Madrid 28041 Spain Details
*Shaded cells indicate that there was no data available from for the field